Product Images Lansoprazole

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 7 images provide visual information about the product associated with Lansoprazole NDC 68071-2274 by Nucare Pharmaceuticals,inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

PDP - 68071 2274 6

PDP - 68071 2274 6

This is a description of Lansoprazole15mg capsules manufactured by NuCare Pharmaceuticals, Inc. The capsules are delayed-release and contain 15mg of Lansoprazoke USP in the form of enteric-coated pellets. Each bottle contains 60 capsules, with the NDC code 68071-2274-06. The capsules are green and white, oblong-shaped, and have "Lifestar" imprinted on the cap and "806" on the body. They should be stored at a controlled temperature of 59-86°F and kept out of reach of children. The expiration date and lot number are also printed on the packaging. For any concerns, contact 1-800-FDA-1088.*

f53ca2be-a290-4157-ad95-d24dfe3344f9-01 - f53ca2be a290 4157 ad95 d24dfe3344f9 01

f53ca2be-a290-4157-ad95-d24dfe3344f9-01 - f53ca2be a290 4157 ad95 d24dfe3344f9 01

f53ca2be-a290-4157-ad95-d24dfe3344f9-02 - f53ca2be a290 4157 ad95 d24dfe3344f9 02

f53ca2be-a290-4157-ad95-d24dfe3344f9-02 - f53ca2be a290 4157 ad95 d24dfe3344f9 02

This is a chart showing the mean severity of heartburn experienced by patients receiving different treatments over a period of 6 days. The treatments include a placebo, lansoprazole 15mg, and lansoprazole 30mg. The mean severity of heartburn is rated on a scale of 0 to 3, with 0 indicating no heartburn and 3 indicating severe heartburn.*

f53ca2be-a290-4157-ad95-d24dfe3344f9-03 - f53ca2be a290 4157 ad95 d24dfe3344f9 03

f53ca2be-a290-4157-ad95-d24dfe3344f9-03 - f53ca2be a290 4157 ad95 d24dfe3344f9 03

The text is describing a chart that shows the mean severity of night heartburn for evaluable patients in a study over a course of days from the start of treatment. The severity is rated on a scale of 0 to 3, with 0 being no heartburn and 3 being severe heartburn. The chart compares the severity of heartburn for patients taking a placebo, lansoprazole 15mg QD, and lansoprazole 30mg QD. The chart shows that on average, patients taking lansoprazole experienced less severe heartburn than those taking the placebo, and those taking the higher dose of lansoprazole experienced even less severe heartburn than those taking the lower dose.*

f53ca2be-a290-4157-ad95-d24dfe3344f9-06 - f53ca2be a290 4157 ad95 d24dfe3344f9 1

f53ca2be-a290-4157-ad95-d24dfe3344f9-06 - f53ca2be a290 4157 ad95 d24dfe3344f9 1

f53ca2be-a290-4157-ad95-d24dfe3344f9-07 - f53ca2be a290 4157 ad95 d24dfe3344f9 2

f53ca2be-a290-4157-ad95-d24dfe3344f9-07 - f53ca2be a290 4157 ad95 d24dfe3344f9 2

Image - f53ca2be a290 4157 ad95 d24dfe3344f9 6

Image - f53ca2be a290 4157 ad95 d24dfe3344f9 6

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.